Your browser doesn't support javascript.
loading
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
Jeppesen, P B; Gilroy, R; Pertkiewicz, M; Allard, J P; Messing, B; O'Keefe, S J.
Affiliation
  • Jeppesen PB; Department of Gastroenterology CA-2121, Rigshospitalet, Copenhagen, Denmark. bekker@dadlnet.dk
Gut ; 60(7): 902-14, 2011 Jul.
Article in En | MEDLINE | ID: mdl-21317170

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Short Bowel Syndrome / Gastrointestinal Agents / Parenteral Nutrition / Fluid Therapy Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Gut Year: 2011 Document type: Article Affiliation country: Dinamarca Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Short Bowel Syndrome / Gastrointestinal Agents / Parenteral Nutrition / Fluid Therapy Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Gut Year: 2011 Document type: Article Affiliation country: Dinamarca Country of publication: Reino Unido